Advanced Soft Tissue Sarcoma Clinical Trials

33 clinical trials for Advanced Soft Tissue Sarcoma across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial — RECRUITING · PHASE2
• Actinium Therapy for Late-stage Aggressive Sarcomas — RECRUITING · PHASE1
• Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY) — RECRUITING · PHASE2
• Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma — RECRUITING · PHASE1
• Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas — RECRUITING · PHASE2
• A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma — RECRUITING · PHASE2
• Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor — RECRUITING · PHASE1
• SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma — RECRUITING · PHASE1
• LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma — RECRUITING · PHASE1
• Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma — RECRUITING
• Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma — RECRUITING · NA
• A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma — NOT_YET_RECRUITING · PHASE2
• Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas — ACTIVE_NOT_RECRUITING · PHASE1
• Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas — ACTIVE_NOT_RECRUITING · PHASE2
• Lurbinectedin + Doxorubicin In Leiomyosarcoma — ACTIVE_NOT_RECRUITING · PHASE1
• Combining Epigenetic And Immune Therapy to Beat Cancer. — COMPLETED · PHASE2
• Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma — TERMINATED · PHASE1
• Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas — TERMINATED · PHASE1
• Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients — OTHER · PHASE3
• Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas — ACTIVE_NOT_RECRUITING · PHASE1
• Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments. — COMPLETED · PHASE2
• Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma — WITHDRAWN · PHASE3
• Camsirubicin + Pegfilgrastim to Determine MTD in ASTS — TERMINATED · PHASE1
• Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas — TERMINATED · PHASE1
• A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma — TERMINATED · PHASE3
• Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors — TERMINATED · PHASE1
• Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery — COMPLETED · PHASE1
• Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS) — COMPLETED
• A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece — COMPLETED
• OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients — TERMINATED · PHASE2
• A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma — COMPLETED · PHASE1
• Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma — COMPLETED · PHASE1

Refine this search